New to Meducation?
Sign up
Already signed up? Log In

Category

Preview
0
0

Treating hypertension in patients with medical comorbidities

There is NICE guidance on blood pressure targets and drug therapy for patients with hypertension and comorbidities such as chronic kidney disease, diabetes, atrial fibrillation, and heart failure  
feeds.bmj.com
almost 4 years ago
Preview
0
0

Treating hypertension in patients with medical comorbidities

There is NICE guidance on blood pressure targets and drug therapy for patients with hypertension and comorbidities such as chronic kidney disease, diabetes, atrial fibrillation, and heart failure  
feeds.bmj.com
almost 4 years ago
Preview
0
0

Treating hypertension in patients with medical comorbidities

There is NICE guidance on blood pressure targets and drug therapy for patients with hypertension and comorbidities such as chronic kidney disease, diabetes, atrial fibrillation, and heart failure  
feeds.bmj.com
almost 4 years ago
Preview
0
0

Treating hypertension in patients with medical comorbidities

There is NICE guidance on blood pressure targets and drug therapy for patients with hypertension and comorbidities such as chronic kidney disease, diabetes, atrial fibrillation, and heart failure  
feeds.bmj.com
almost 4 years ago
Preview
0
0

Treating hypertension in patients with medical comorbidities

There is NICE guidance on blood pressure targets and drug therapy for patients with hypertension and comorbidities such as chronic kidney disease, diabetes, atrial fibrillation, and heart failure  
feeds.bmj.com
almost 4 years ago
Preview
0
0

Treating hypertension in patients with medical comorbidities

There is NICE guidance on blood pressure targets and drug therapy for patients with hypertension and comorbidities such as chronic kidney disease, diabetes, atrial fibrillation, and heart failure  
feeds.bmj.com
almost 4 years ago
Preview
0
0

FDA Expands Use of Single-Use Antiemetic Fosaprepitant

The FDA has approved single-dose fosaprepitant dimeglumine to prevent delayed nausea and vomiting in patients who receive moderately emetogenic chemotherapy.  
medscape.com
almost 4 years ago
Preview
0
0

Must-Know EM Pharmacotherapy Articles of 2015

Dr. Bryan Hayes lists his top 10 must-know EM pharmacotherapy articles of 2015, along with a bonus article and his favorite article of the year.  
aliem.com
almost 4 years ago
Preview
0
2

Must-Know EM Pharmacotherapy Articles of 2015

Dr. Bryan Hayes lists his top 10 must-know EM pharmacotherapy articles of 2015, along with a bonus article and his favorite article of the year.  
aliem.com
almost 4 years ago
Preview
0
1

First Chemo 'Antidote' Cuts Deaths From 5-FU Toxicity

The first and only approved antidote for severe toxicity related to a chemotherapy overdose dramatically reduces mortality.  
medscape.com
almost 4 years ago
3
5
307

Corticosteroids Overview

Review of corticosteroids pathophysiology, pharmacology, and pharmacotherapy  
Dustie Sieg
almost 4 years ago
Preview
0
0

Anti-cancer drug treatment for gestational trophoblastic neoplasia (GTN) that does not respond to first-line treatment or that re-occurs | Cochrane

This review concerns anti-cancer drug treatment for women with GTN that does not respond to first-line treatment or that re-occurs. GTN is the name given to a type of cancer that arises from placental tissue following pregnancy, most frequently a molar pregnancy. Molar pregnancies are benign abnormal growths of placental tissue inside the womb. Most are cured by evacuation (D&C) of the womb, however, in up to 20% of cases they become malignant. GTN is usually very responsive to anti-cancer drugs (chemotherapy), however, these drugs can be toxic, therefore the aim of treatment is to achieve a cure with the least side effects. To help doctors select the most appropriate treatment for women with GTN, the disease is classified as low- or high-risk according to specific risk factors.  
cochrane.org
almost 4 years ago
Preview
0
6

New Hodgkin's Protocol: Brentuximab Vedotin and Nivolumab

The new treatment protocol may advance the goal of phasing out the use of nonspecific, cytotoxic chemotherapy as a treatment for this disease.  
medscape.com
almost 4 years ago
Preview
0
0

Fewer American Cancer Patients Now Dying in Hospitals

Fewer cancer patients die in the hospital in the United States than in other developed country, but of those who do, more receive chemotherapy during the last 6 months of life than in other nations.  
medscape.com
almost 4 years ago
Preview
0
1

Advances in Infusion Technology: Emerging Concepts in Chemotherapy and Supportive Care CME/CE

John P. Leonard, MD (Activity Moderator); Val R. Adams, PharmD, FCCP, BCOP; Barbara Barnes Rogers, CRNP, MN, AOCN, ANP-BC  
medscape.org
almost 4 years ago
Preview
0
0

Chemotherapy could make breast cancer patients more vulnerable to common infections

Patients with breast cancer who are treated with chemotherapy have depleted immune systems, leaving them vulnerable to common infections, researchers have warned in the journal Breast Cancer Research.1 They said that revaccination against common immunogens may need to be considered in some cases.  
feeds.bmj.com
almost 4 years ago
Preview
0
0

Sisters help launch cancer study aiming to end chemotherapy - BBC News

The first patients have had their DNA analysed in a massive study that aims to replace chemotherapy.  
bbc.co.uk
almost 4 years ago
Preview
0
9

Can Gonads Be Protected During Chemotherapy?

Can the use of gonadotropin-releasing hormone analogue during chemotherapy protect the ovaries from gonadal toxicity and preserve fertility?  
medscape.com
almost 4 years ago